Treatment for Nephrotic Syndrome

Phase-Based Progress Estimates
Cedars-Sinai Medical Center, Los Angeles, CA
Nephrotic Syndrome
Eligible conditions

Study Summary

This study is evaluating whether a test of the heart's ability to respond to stress can help identify women with MCD.

See full description

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Nephrotic Syndrome

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Nephrotic Syndrome. Measurement will happen over the course of 24 hours.

24 hours
Cardiovascular Reactivity (CVR)

Trial Safety

Safety Progress

1 of 3

Other trials for Nephrotic Syndrome

Trial Design

0 Treatment Group

This trial requires 105 total participants across 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 hours
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 24 hours for reporting.

Who is running the study

Principal Investigator
N. B. M.
Noel Bairey Merz, Director
Cedars-Sinai Medical Center

Closest Location

Cedars-Sinai Medical Center - Los Angeles, CA

Eligibility Criteria

This trial is for female patients aged 18 and older. There are 8 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Women with symptomatic angina or angina equivalent;
Age > 18 yrs old;
No obstructive CAD at coronary angiography (performed within the previous 24 months);
Competent to give informed consent.
Women without signs and symptoms of myocardial ischemia (chest pain, abnormal stress testing, abnormal noninvasive testing);
No cardiac risk factors by Framingham/NCEP criteria;
Age (35-65) matched to the WISE MCD population;
A normal maximal exercise stress test.

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Nephrotic Syndrome by sharing your contact details with the study coordinator.